In Plain English
Johnson & Johnson is splitting off DePuy Synthes (Orthopedics Unit) into its own separate, publicly-traded company. Shareholders typically receive shares in the new entity automatically. This was recently announced.
DePuy Synthes (Orthopedics Unit) will become a separate public company
Deal Progress
RUMORED
ANNOUNCED
PENDING
ACTIVE
COMPLETED
Parent Company
Johnson & Johnson
JNJ
Healthcare
SpinCo / Target
DePuy Synthes (Orthopedics Unit)
Announced
Oct 14, 2025
Oct 14, 25
Expected
18 to 24 months
Market Cap
Not disclosed
Deal Value
Not disclosed
Summary
Johnson & Johnson exploring spin-off of its DePuy Synthes orthopedics unit.
Deal Flow Timeline
Key milestones from announcement to expected completion
Deal Announced
2025-10-14
COMPLETEDForm 10 Filed
UPCOMINGIRS Tax Ruling
UPCOMINGShareholder Approval
UPCOMINGRecord Date
18 to 24 months
UPCOMINGDistribution / Completion
18 to 24 months
UPCOMINGDeal Announced
COMPLETEDInitial public announcement of the transaction.
2025-10-14
Form 10 Filed
UPCOMINGRegistration statement filed with the SEC for the new entity.
IRS Tax Ruling
UPCOMINGPrivate letter ruling confirming tax-free treatment.
Shareholder Approval
UPCOMINGBoard and/or shareholder vote to approve the separation.
Record Date
UPCOMINGRecord date for distribution of new shares.
Est: 18 to 24 months
Distribution / Completion
UPCOMINGShares of the new entity distributed to shareholders.
Est: 18 to 24 months